Anticarbamazepine antibody was detected in a patient who had clinical signs of serum sickness induced by carbamazepine. Skin rash, fever, oedema, and lymphadenopathy are classic signs of severe adverse reaction, but although immunological hypersensitivity is thought to be a contributory factor, the presence of anticarbamazepine antibody has not previously been reported to our knowledge.
erythematosus have been reported.2 3 In some cases the skin rash is part of a severe illness affecting several organs, and immunological hypersensitivity is thought to contribute to the skin reaction.3 4 So far, however, we know of no report of the presence of anticarbamazepine antibody in any patient with severe skin reactions.
We present a patient with the typical clinical manifestations of serum sickness, fever, eruption with oedema (particularly around the face and neck), and lymphadenopathy. The laboratory findings showed a decrease in complement C4 and an increase in C3a and C4a activity. Anticarbamazepine antibody was detected in the serum using an enzyme linked immunosorbent assay (ELISA). Methods BALB/C mice were given carbamazepine (1 g/kg) orally, and bled six hours later. The serum was used as the antigen.
The anticarbamazepine antibody of serum from the patient was analysed by ELISA, a procedure that has been described elsewhere. Case report An 8 year old girl was admitted with fever and skin rash. Thirty seven days before admission carbamazepine 200 mg (10 mg/kg) had been prescribed because of a complex partial seizure. Twenty seven days before admission the first skin rash had appeared on her cheeks, but this disappeared within a few days. Twenty three days before admission, the dose of carbamazepine had been increased to 300 mg. The day before admission she had again developed maculopapular erythema on her face and neck, this time accompanied by fever. Her past history and family history were not helpful. On examination she had maculopapular erythema on her face, neck, and trunk, and her body temperature was 40°C. Several bilateral cervical lymph nodes were enlarged to less than 2 cm in diameter and the liver was also enlarged. Laboratory findings on admission included aspartate aminotransferase activity 108 U/1, alanine aminotransferase activity 107 U/1, C3 1 29 g/l, C4 384 mg/l; white blood cell count, haemoglobin concentration, and platelet count were normal. Carbamazepine had been discontinued because of suspected hypersensitivity, but the high fever and skin rash persisted. A week later the facial oedema was so bad that she could not open her eyes and she had developed a productive cough. Crackles could be heard in her chest and an x ray film showed mild bronchopneumonia in the right middle lobe. She also had watery diarrhoea several times a day.
The pneumonia and the diarrhoea resolved within a few days without any special treatment, and the fever and skin rash subsided on the 15th day in hospital. Cultures During this seven to 10 day (up to three week) period, the drugprotein complex stimulates production of a sufficient number of activated immune effector cells and antibodies to cause the allergic reaction.6 8 It is rational to attribute the skin rash induced by carbamazepine to an immunological disorder, because 80% of carbamazepine can bind to proteinl' and the skin rash does not appear for seven days. 1 We have described a patient who showed the classic clinical picture of serum sickness.7 Carbamazepine specific delayed type hypersensitivity was detected by patch test, and carbamazepine specific antibody was also detected using an ELISA. These findings showed that carbamazepine specific T 
